Related Experiment Video

Updated: May 26, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

[Risk factors for infection with extended-spectrum beta-lactamase-producing strains in children]

Jian-Hua Liu1, Xin-Feng Liu, Jin-Feng Shuai

  • 1Children's Hospital of Hebei Province, Shijiazhuang 050031, China. liujianhua@sina.com

Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics
|December 17, 2011
PubMed

Insights

Infections with extended-spectrum beta-lactamase (ESBL) producing strains in children are linked to prolonged third-generation cephalosporin use, invasive procedures, and pediatric intensive care unit (PICU) admission. These factors significantly increase the risk of ESBL infections in pediatric patients.

Area of Science:

  • Infectious Diseases
  • Pediatric Medicine
  • Microbiology

Context:

  • Extended-spectrum beta-lactamase (ESBL) producing strains pose a significant threat in pediatric healthcare settings.
  • Lower respiratory tract infections (LRTI) in children are common and can be complicated by multidrug-resistant organisms.
  • Understanding risk factors for ESBL infections is crucial for effective prevention and treatment strategies.

Purpose:

  • To identify and analyze the risk factors associated with infections caused by extended-spectrum beta-lactamase (ESBL) producing strains in pediatric patients.
  • To differentiate between univariate and independent risk factors for ESBL infections in children with LRTI.

Summary:

  • A retrospective analysis of 242 pediatric patients with LRTI identified several risk factors for ESBL infections.
  • Independent risk factors identified through multivariate logistic regression include prolonged use of third-generation cephalosporins (>3 days), repeated phlegm suctioning, tracheal intubation, nasogastric tube insertion, and PICU admission.
  • These findings highlight the importance of judicious antibiotic use and minimizing invasive procedures in pediatric patients.

Impact:

  • The study provides critical insights into modifiable risk factors for ESBL infections in children.
  • Results can inform clinical guidelines and infection control practices to reduce the incidence of ESBL-related morbidity and mortality in pediatric populations.
  • This research contributes to the broader understanding of antimicrobial resistance mechanisms and their clinical implications in vulnerable pediatric patients.
Abstract

More Related Videos

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates08:32

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates

Published on: February 17, 2023

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes08:58

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes

Published on: March 3, 2023

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...